Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shariat SF et al. – While the status of individual molecular markers does not add sufficient value to outcome prediction in patients with advanced urothelial carcinoma of the bladder, combinations of molecular markers may improve molecular staging, prognostication and possibly prediction of response to therapy.


Related Articles

Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
Anti-Cancer Drugs, 12/09/09    Relevance Score: 80%

Organ-sparing strategies in the management of invasive bladder cancer
Expert Review of Anticancer Therapy, 12/08/09    Relevance Score: 80%

Increased bladder cancer risk among workers exposed to o-toluidine and aniline: A reanalysis
Occupational and Environmental Medicine, 11/06/09    Relevance Score: 79%

Urinary bladder auto augmentation using INTEGRA and SURGISIS
Pediatric Surgery International, 11/25/09    Relevance Score: 68%

Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms
Internet Source, 11/23/09    Relevance Score: 68%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address